Table 1.
Demographic and clinical characteristics of the study participants
| Demographic/Clinical Characteristic |
Median or Frequency (percent) |
|---|---|
| Age | 73 years |
| Time Since Diagnosis | 46 days |
| Sex | |
| Male | 35 (37.2%) |
| Female | 59 (62.8%) |
| Race/Ethnicity | |
| Caucasian/White | 90 (95.7%) |
| Black/African American | 2 (2.1%) |
| Hispanic/Latino | 2 (2.1%) |
| Education | |
| Some high school or less | 7 (7.4%) |
| High school graduate | 31 (33.0%) |
| Some college or technical college | 27 (28.7%) |
| College graduate | 29 (30.9%) |
| Marital Status | |
| Married | 61 (64.9%) |
| Divorced/Separated | 11 (11.7%) |
| Widowed | 22 (23.4%) |
| Living Arrangements | |
| Alone | 21 (22.3%) |
| Spouse/Partner | 58 (61.7%) |
| All other living arrangements | 15 (16.0%) |
| Tumor Site | |
| Gastrointestinal (not colorectal) | 15 (16.0%) |
| Colorectal | 17 (18.1%) |
| Breast | 13 (13.8%) |
| Lung | 25 (26.6%) |
| Gynecologic | 13 (13.8%) |
| All others | 11 (11.7%) |
| Tumor Stage | |
| Not staged/ill-defined | 2 (2.1%) |
| Stage I | 7 (7.4%) |
| Stage II | 11 (11.7%) |
| Stage III | 51 (54.3%) |
| Stage IV | 23 (24.5%) |
| Regimen Type | |
| Adjuvant | 36 (38.3%) |
| Neo-adjuvant | 15 (16.0%) |
| Therapeutic | 40 (42.6%) |
| Missing/Unknown | 3 (3.2%) |